660 related articles for article (PubMed ID: 18264117)
1. Chromatin control of herpes simplex virus lytic and latent infection.
Knipe DM; Cliffe A
Nat Rev Microbiol; 2008 Mar; 6(3):211-21. PubMed ID: 18264117
[TBL] [Abstract][Full Text] [Related]
2. Chromatin dynamics during herpes simplex virus-1 lytic infection.
Placek BJ; Berger SL
Biochim Biophys Acta; 2010; 1799(3-4):223-7. PubMed ID: 20139038
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cellular death signals in the reactivation of herpes simplex virus type 1 and lambda bacteriophage from a latent state.
Panet A; Braun E; Honigman A; Steiner I
J Theor Biol; 2005 Sep; 236(1):88-94. PubMed ID: 15967186
[TBL] [Abstract][Full Text] [Related]
4. Biological and molecular aspects on herpes simplex virus latency.
Lycke E
Scand J Infect Dis Suppl; 1990; 69():113-9. PubMed ID: 2175937
[TBL] [Abstract][Full Text] [Related]
5. Restarting Lytic Gene Transcription at the Onset of Herpes Simplex Virus Reactivation.
Cliffe AR; Wilson AC
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807236
[TBL] [Abstract][Full Text] [Related]
6. CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection.
Lee JS; Raja P; Pan D; Pesola JM; Coen DM; Knipe DM
mBio; 2018 Feb; 9(1):. PubMed ID: 29437926
[TBL] [Abstract][Full Text] [Related]
7. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
Sekizawa T; Openshaw H; Itoyama Y
J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
[TBL] [Abstract][Full Text] [Related]
8. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
Fraser NW; Valyi-Nagy T
Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
[No Abstract] [Full Text] [Related]
9. Immunity in latent Herpes simplex virus infection.
Bystrická M; Russ G
Acta Virol; 2005; 49(3):159-67. PubMed ID: 16178513
[TBL] [Abstract][Full Text] [Related]
10. A Herpesviral Lytic Protein Regulates the Structure of Latent Viral Chromatin.
Raja P; Lee JS; Pan D; Pesola JM; Coen DM; Knipe DM
mBio; 2016 May; 7(3):. PubMed ID: 27190217
[TBL] [Abstract][Full Text] [Related]
11. The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1.
Mador N; Panet A; Steiner I
J Neurovirol; 2002 Dec; 8 Suppl 2():97-102. PubMed ID: 12491159
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biology of pathogenesis by herpesvirus].
Barrón BL; Vales N
Rev Latinoam Microbiol; 1991; 33(1):77-85. PubMed ID: 1670258
[TBL] [Abstract][Full Text] [Related]
13. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection.
Wang QY; Zhou C; Johnson KE; Colgrove RC; Coen DM; Knipe DM
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16055-9. PubMed ID: 16247011
[TBL] [Abstract][Full Text] [Related]
14. The continuing problem of herpes simplex virus persistence.
Rajcáni J; Szántó J
Acta Virol; 1983 Sep; 27(5):442-50. PubMed ID: 6139950
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus.
Taylor TJ; Brockman MA; McNamee EE; Knipe DM
Front Biosci; 2002 Mar; 7():d752-64. PubMed ID: 11861220
[TBL] [Abstract][Full Text] [Related]
16. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
Lachmann RH; Efstathiou S
Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
[TBL] [Abstract][Full Text] [Related]
17. [Present status and task the in study of pathophysiologic mechanism of latent herpes simplex virus infection and the viral re-activation].
Minagawa H
Fukuoka Igaku Zasshi; 1995 Jul; 86(7):299-303. PubMed ID: 7665138
[No Abstract] [Full Text] [Related]
18. Kinetics of facultative heterochromatin and polycomb group protein association with the herpes simplex viral genome during establishment of latent infection.
Cliffe AR; Coen DM; Knipe DM
mBio; 2013 Jan; 4(1):. PubMed ID: 23322639
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
20. Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies.
Kristie TM
Virology; 2015 May; 479-480():555-61. PubMed ID: 25702087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
